rs767294741
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS2_Supporting
The NM_182961.4(SYNE1):c.12272A>G(p.Asp4091Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,936 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.12272A>G | p.Asp4091Gly | missense_variant | Exon 75 of 146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.12272A>G | p.Asp4091Gly | missense_variant | Exon 75 of 146 | 1 | NM_182961.4 | ENSP00000356224.5 | ||
SYNE1 | ENST00000423061.6 | c.12059A>G | p.Asp4020Gly | missense_variant | Exon 74 of 146 | 1 | ENSP00000396024.1 | |||
SYNE1 | ENST00000471834.1 | n.5410A>G | non_coding_transcript_exon_variant | Exon 18 of 19 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251428Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135882
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461692Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727144
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74382
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
- -
not specified Uncertain:1
- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Uncertain:1
This variant has not been reported in the literature in individuals with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 290701). This variant is present in population databases (rs767294741, ExAC 0.03%). This sequence change replaces aspartic acid with glycine at codon 4020 of the SYNE1 protein (p.Asp4020Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Arthrogryposis multiplex congenita 3, myogenic type Uncertain:1
The SYNE1 p.D4091G variant was not identified in the literature but was identified in dbSNP (ID: rs767294741) and ClinVar (classified as uncertain significance by EGL Genetic Diagnostics and Athena Diagnostics). The variant was identified in control databases in 9 of 251428 chromosomes at a frequency of 0.00003580, and was observed at the highest frequency in the Latino population in 7 of 34586 chromosomes (freq: 0.0002024) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.D4091 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Autosomal recessive ataxia, Beauce type Uncertain:1
The SYNE1 p.D4091G variant was not identified in the literature but was identified in dbSNP (ID: rs767294741) and ClinVar (classified as uncertain significance by EGL Genetic Diagnostics and Athena Diagnostics). The variant was identified in control databases in 9 of 251428 chromosomes at a frequency of 0.00003580, and was observed at the highest frequency in the Latino population in 7 of 34586 chromosomes (freq: 0.0002024) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.D4091 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Uncertain:1
The SYNE1 p.D4091G variant was not identified in the literature but was identified in dbSNP (ID: rs767294741) and ClinVar (classified as uncertain significance by EGL Genetic Diagnostics and Athena Diagnostics). The variant was identified in control databases in 9 of 251428 chromosomes at a frequency of 0.00003580, and was observed at the highest frequency in the Latino population in 7 of 34586 chromosomes (freq: 0.0002024) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.D4091 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at